Cree Guides Higher Revenues, But Lower Profits. Cree, Inc. (NASDAQ:CREE) stock has lost 10% of its value after the semiconductor company announced weak financial results for the third quarter (3Q) of its 2014 fiscal year (FY14) yesterday after market close. Cree, Inc. (NASDAQ:CREE) shares after opening at $53.05 moved to $53.40 on last trade day and at the end of the day closed at $51.04. Company price to sales ratio in past twelve months was calculated as 4.06 and price to cash ratio as 5.24. Cree, Inc. (NASDAQ:CREE) showed a negative weekly performance of -8.05%.
Zix Corp. (NASDAQ:ZIXI) has reported an ending backlog of USD65.9m, an increase of 10.6 percent year-over-year and the company´s eighth consecutive quarterly record in backlog. Zix Corporation (NASDAQ:ZIXI) shares fell -10.57% in last trading session and ended the day on $3.47. ZIXI return on equity ratio is recorded as 15.90% and its return on assets is 11.80%. Zix Corporation (NASDAQ:ZIXI) yearly performance is -6.72%.
Castlight Health, Inc. (NYSE:CSLT), a leading provider of enterprise healthcare cloud software, announced that it has scheduled a conference call to review its first quarter 2014 results (ended March 31, 2014) for Wednesday, May 7, 2014. Castlight Health Inc. (NYSE:CSLT) shares moved down -6.21% in last trading session and was closed at $15.70, while trading in range of $15.51 – $16.75. Castlight Health Inc. (NYSE:CSLT) year to date (YTD) performance is -60.55%.
The gross profit margin for Quality Systems, Inc. (NASDAQ:QSII) is rather high; currently it is at 59.79%. Regardless of QSII’s high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, QSII’s net profit margin of -11.56% significantly underperformed when compared to the industry average. Quality Systems, Inc. (NASDAQ:QSII) weekly performance is -5.76%. On last trading day company shares ended up $14.88. Quality Systems, Inc. (NASDAQ:QSII) distance from 50-day simple moving average (SMA50) is -12.35%. Analysts mean target price for the company is $19.19.